Expert Review of Molecular Diagnostics

Papers
(The H4-Index of Expert Review of Molecular Diagnostics is 21. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)
ArticleCitations
Harnessing the potential of genomic characterization of mutational profiles to improve early diagnosis of lung cancer120
Clinicopathological, etiological and molecular characteristics of intrahepatic cholangiocarcinoma subtypes classified by mucin production and immunohistochemical features92
Evolution and future of cervical cancer screening: from cytology to primary HPV testing and the impact of vaccination52
What makes a « good » companion diagnostic in thoracic oncology?46
Recent updates in the development of molecular assays for the rapid identification and susceptibility testing of MRSA45
Mild behavioral impairment and neurodegeneration: time for a biomarker-based assessment44
Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence41
Cost analyses for malaria molecular diagnosis for research planners in India and beyond35
Molecular point-of-care testing in the community pharmacy setting: current status and future prospects34
Cancer cell-derived extracellular vesicles activate hepatic stellate cells in colorectal cancer33
Alzheimer’s disease: a scoping review of biomarker research and development for effective disease diagnosis31
Functional proteomic analysis, a missing piece for understanding clonal evolution and cooperation in the tissue microecology28
Diagnosing thrombophilia: the case for genetic or functional testing?28
A novel anoikis-related signature predicts prognosis risk and treatment responsiveness in diffuse large B-cell lymphoma27
Unlocking the power of biomarkers: transforming the diagnosis of acute respiratory distress syndrome25
Diagnostic approach to leptomeningeal involvement in diffuse large B-cell lymphoma25
The MALAT1-breast cancer interplay: insights and implications24
Genetic risk and gastric cancer: polygenic risk scores in population-based case-control study23
How mitochondrial DNA complicates pre-implantation genetic screening and management23
Clinical application of noninvasive prenatal testing in twin pregnancies: a single-center experience23
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease22
Noncoding RNAs as a potential biomarker for the prognosis of bladder cancer: a systematic review and meta-analysis21
Prognostic and survival impact of BCL9 and RPS6KB1 copy number variation detected from circulating free DNA in hepatocellular carcinoma21
0.034891128540039